Brain Cancer Research Institute – Trademark Portfolio
Entity Type: 99
Brain Cancer Research Institute holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CURESCIENCE and TRANSFORMING HOPE INTO CURE. The owner is based in San Diego, CA.
3525 Del Mar Heights Road, Ste 133
San Diego, CA 92130
Showing of trademarks Trademarks
Trademark Classifications
Brain Cancer Research Institute's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Brain Cancer Research Institute have?
Brain Cancer Research Institute has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Brain Cancer Research Institute file in?
Brain Cancer Research Institute files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Brain Cancer Research Institute's most well-known trademarks?
Brain Cancer Research Institute's registered trademark portfolio includes well-known marks such as CURESCIENCE and TRANSFORMING HOPE INTO CURE. These are among 2 currently registered trademarks in the portfolio.
What is Brain Cancer Research Institute's trademark registration success rate?
Brain Cancer Research Institute has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.